Lysbeth Ten Bloemendaal
Amsterdam, NH 1105AZ, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Long-Term Effects of Biliverdin Reductase a Deficiency in Ugt1-/- Mice: Impact on Redox Status and Metabolism.
Journal: Antioxidants (Basel, Switzerland)
Published: October 11, 2021
Reduced spontaneous itch in mouse models of cholestasis.
Journal: Scientific reports
Published: October 02, 2020
Efficacy of AAV8-hUGT1A1 with Rapamycin in neonatal, suckling, and juvenile rats to model treatment in pediatric CNs patients.
Journal: Molecular therapy. Methods & clinical development
Published: September 11, 2020
A Quantitative In Vitro Potency Assay for Adeno-Associated Virus Vectors Encoding for the UGT1A1 Transgene.
Journal: Molecular therapy. Methods & clinical development
Published: April 29, 2020
Liver-directed gene therapy results in long-term correction of progressive familial intrahepatic cholestasis type 3 in mice.
Journal: Journal of hepatology
Published: January 18, 2019
The P4-ATPase ATP9A is a novel determinant of exosome release.
Journal: PloS one
Published: July 16, 2018
Cre Recombinase Mediates the Removal of Bacterial Backbone to Efficiently Generate rSV40.
Journal: Molecular therapy. Methods & clinical development
Published: September 19, 2017
Polyinosinic acid blocks adeno-associated virus macrophage endocytosis in vitro and enhances adeno-associated virus liver-directed gene therapy in vivo.
Journal: Human gene therapy
Published: September 10, 2013
Adeno-associated viral vector serotype 5 poorly transduces liver in rat models.
Journal: PloS one
Published: August 09, 2013
In the rat liver, Adenoviral gene transfer efficiency is comparable to AAV.
Journal: Gene therapy
Published: June 28, 2013
Ezetimibe: A biomarker for efficacy of liver directed UGT1A1 gene therapy for inherited hyperbilirubinemia.
Journal: Biochimica et biophysica acta
Published: January 27, 2012
Showing 1-11 of 11
Last Updated: 09/26/2026